3-Piperidinamine, N,4-dimethyl-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-, (3R,4R)-

3-Piperidinamine, N,4-dimethyl-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-, (3R,4R)- Struktur
2097982-05-1
CAS-Nr.
2097982-05-1
Englisch Name:
3-Piperidinamine, N,4-dimethyl-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-, (3R,4R)-
Synonyma:
3-Piperidinamine, N,4-dimethyl-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-, (3R,4R)-
CBNumber:
CB15909561
Summenformel:
C13 H19 N5
Molgewicht:
245.32
MOL-Datei:
2097982-05-1.mol

3-Piperidinamine, N,4-dimethyl-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-, (3R,4R)- Eigenschaften

Sicherheit

3-Piperidinamine, N,4-dimethyl-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-, (3R,4R)- Chemische Eigenschaften,Einsatz,Produktion Methoden

3-Piperidinamine, N,4-dimethyl-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-, (3R,4R)- Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


3-Piperidinamine, N,4-dimethyl-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-, (3R,4R)- Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 10)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
ShenZhen H&D Pharmaceutical Technology Co., LTD
+8618627948422
sale@hdimpurity.com China 3681 58
Runte International Trade Limited
19565631292
lucky@sdruntechem.com China 296 58
S.Z. PhyStandard Bio-Tech. Co., Ltd. 0755-4000505016 13380397412
3001272453@qq.com China 5158 50
Scinova Biotech(Guangzhou) Co., Ltd. 13268215580
scinova_sales@163.com China 7025 58
ShenZhen H&D Pharmaceutical Technology Co., LTD 18126517264
2850476883@qq.com China 7932 58
Hubei Moco Chemical Co., Ltd. 18627753421; 18627756402
3001051413@qq.com China 19360 58
Guangzhou Viocon Pharmaceutical Technology Co., Ltd 13726739909
chenhuini@cti-cert.com China 507 58
Biosynth Biological Technology (Suzhou) Co Ltd 51288865780
sales@biosynth.com China 6051 58
Hangzhou Yiyun Guoke Biotechnology Co., Ltd. 17717523804
1211221625@qq.com China 8587 58

  • 3-Piperidinamine, N,4-dimethyl-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-, (3R,4R)-
  • 2097982-05-1
Copyright 2019 © ChemicalBook. All rights reserved